Risk Appreciation for Living Kidney Donors: Another New Subspecialty?

American Journal of Transplantation

Volumn 4, Issue 5, 2004, Pages 694-697

  Steiner, Robert W ^a  

^a UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

Author keywords

Kidney transplantation; Living kidney donors

Indexed keywords

HUMAN; KIDNEY FAILURE; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; LIVING DONOR; PATIENT COUNSELING; POLICY; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; REVIEW; RISK ASSESSMENT; SAFETY;

HUMANS; KIDNEY FAILURE, CHRONIC; KIDNEY TRANSPLANTATION; LIVING DONORS; RISK ASSESSMENT; TISSUE AND ORGAN PROCUREMENT;

EID: 2442619475     PISSN: 16006135     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1600-6143.2004.00424.x     Document Type: Review

References (17)

1. Bia MJ, Ramos EL, Danovitch GM et al. Evaluation of living renal donors. Transplantation 1995; 60: 322-327.
2. Burt VL, Cutler JA, Higgins M et al. Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the health examination surveys, 1960-91. Hypertension 1995; 26: 60-69.
3. Stamatelou K, Francis M, Jones C, Nyberg L, Curhan G. Time trends in reported prevalence of kidney stones in the United States. Kidney Int 2003; 63: 1817-1823.
4. 2, U.S. Renal Data System: Excerpts from the USRDS 2000 Annual Data Report. Atlas of End Stage Renal Disease in the United States. Am J Kidney Dis 2003; 3S: S1-S239.
5. U.S. Census Bureau. Statistical abstract of the United States: 2001: http//www.census.gov/.
6. Steiner RW, Danovitch GM. The medical evaluation and risk of end stage renal disease for living kidney donors. In: Steiner RW (ed). Educating, Evaluating, and Selecting Living Kidney Donors. Dordrecht: Kluwer, 2004.
7. Bruno G, Biggeri A, Merletti F et al. Low incidence of end-stage renal disease and chronic renal failure in type 2 diabetes. Diabetes Care 2003; 26: 2353-2358.
8. Vasan RS, Martin GL, Leip EP et al. Impact of high normal blood pressure on the risk of cardiovascular disease. NEJM 2001; 345: 1291-1297.
9. http://diabetes.niddk.nih.gov/dm/pubs/statistics/index.htm.
10. Kiberd BA, Clase CM. Cumulative risk for developing end-stage renal disease in the U.S. population. J Am Soc Nephrol 2002; 13: 1635-1644.
11. Kasiske BL, Ma JZ, Louis TA, Swan SK. Long-term effects of reduced renal mass in humans. Kidney Int 1995; 48: 814-819.
12. Fehrman-Ekhol I, Elinder CG, Stenbeck M. Kidney donors live longer. Transplantation 1997; 64: 976-978.
13. Zeier M, Geberth S, Ritz E, Grunfeld JP, Gonzalo A. The effect of uninephrectomy on progression of renal failure in autosomal dominant polycystic kidney disease. J Am Soc Nephrol 1992; 3: 1119-1123.
14. Steiner RW, Gert B. Ethical selection of living kidney donors. Am J Kid Dis 2000; 36: 677-686.
15. Steiner RW, Gert B. A technique for presenting risk and outcome data to potential living renal transplant donors. Transplantation 2001; 71: 1056-1057.
16. Delmonico F, Abecassis M, Adams M et al. Live Organ Donor Consensus Group. Consensus statement on the live organ donor. JAMA 2000; 284: 2919-2926.
17. Bertram DD. The reality and acceptance of risk. JAMA 1980; 244: 1226-1228.